Showing results (251-260 of 285) with videos related to
Sort By:
Pageof 29
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymeraseRobert G Gentles, Steven Sheriff, Brett R Beno, et al.Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.Antimicrobial Agents and Chemotherapy|April 16, 2014
Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymeraseJulie A Lemm, Mengping Liu, Robert G Gentles, et al.International Journal of Hygiene and Environmental Health|September 27, 2025
Impact of infection prevention interventions on neonatal bloodstream infections and mortality in EthiopiaFriederike Lemm, Hailemariam Gebrearegay Haileeyesus, Kiros Weldegerima Gezahegn, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymeraseMin Ding, Feng He, Thomas W Hudyma, et al.Blood|May 10, 2015
The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse modelMatthew D Blunt, Matthew J Carter, Marta Larrayoz, et al.Science Immunology|February 9, 2024
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adultsHelen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, et al.Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2018
Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with <i>In Vivo</i> Antitumor ActivityTara L Peters, Joseph Tillotson, Alison M Yeomans, et al.Nature|April 23, 2010
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectMin Gao, Richard E Nettles, Makonen Belema, et al.Pageof 29